Man Group
ORGO icon

Man Group’s Organogenesis Holdings ORGO Stock Holding History

Man Group’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-96,416
Closed -$270K – 2139
2024
Q2 		$270K Buy
96,416
+3,307
+4% +$8.88K ﹤0.01% 1811
2024
Q1 		$264K Buy
+93,109
New +$316K ﹤0.01% 1955
2023
Q3 		– Sell
-113,328
Closed -$360K – 1705
2023
Q2 		$376K Buy
+113,328
New +$335K ﹤0.01% 1666
2023
Q1 		– Sell
-60,578
Closed -$150K – 1774
2022
Q4 		$163K Buy
60,578
+44,478
+276% +$130K ﹤0.01% 1812
2022
Q3 		$52K Buy
+16,100
New +$72.7K ﹤0.01% 1892
2022
Q2 		– Hold
0
– – – 1939
2021
Q3 		– Sell
-15,100
Closed -$251K – 2036
2021
Q2 		$251K Buy
+15,100
New +$281K ﹤0.01% 1735

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group's ORGO Position: Q3 2024 in Review

Man Group sold out of Organogenesis Holdings (ORGO) in Q3 2024, closing a stake of 96,416 shares — an estimated $270K sold.

Man Group first reported a position in ORGO in Q2 2021 and held it in 6 quarters. The position peaked at $376K in Q2 2023. 112 funds tracked by Wall St. Rank hold ORGO as of Q3 2024.

  • Man Group reported no remaining Organogenesis Holdings position as of Q3 2024 after selling out during the quarter.
  • Man Group sold 96,416 Organogenesis Holdings shares in Q3 2024, an estimated $270K.
  • Man Group first reported a position in Organogenesis Holdings in Q2 2021 and held it in 6 quarters.
  • Man Group's Organogenesis Holdings position peaked at $376K in Q2 2023.
  • 112 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2024.

Based on Man Group's 13F filing for Q3 2024, filed 14 Nov 2024.